As of Apr 25
| +0.83 / +1.84%|
The 2 analysts offering 12-month price forecasts for Medifast Inc have a median target of 46.00, with a high estimate of 49.00 and a low estimate of 43.00. The median estimate represents a +0.13% increase from the last price of 45.94.
The current consensus among 2 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.